Home/Filings/4/0001477449-24-000038
4//SEC Filing

Geshuri Arnnon 4

Accession 0001477449-24-000038

CIK 0001477449other

Filed

Mar 4, 7:00 PM ET

Accepted

Mar 5, 4:07 PM ET

Size

18.5 KB

Accession

0001477449-24-000038

Insider Transaction Report

Form 4
Period: 2024-03-01
Geshuri Arnnon
Chief Human Resources Officer
Transactions
  • Exercise/Conversion

    Common Stock

    2024-03-01+1,17929,199 total
  • Exercise/Conversion

    Common Stock

    2024-03-01+11,47040,669 total
  • Exercise/Conversion

    Common Stock

    2024-03-01+3,90944,578 total
  • Sale

    Common Stock

    2024-03-04$14.52/sh6,108$88,66438,470 total
  • Exercise/Conversion

    Restricted Stock Units

    2024-03-011,1794,717 total
    Common Stock (1,179 underlying)
  • Exercise/Conversion

    Restricted Stock Units

    2024-03-0111,47022,942 total
    Common Stock (11,470 underlying)
  • Award

    Performance Stock Units

    2024-03-01+11,72811,728 total
    Common Stock (11,728 underlying)
  • Exercise/Conversion

    Performance Stock Units

    2024-03-013,9097,819 total
    Common Stock (3,909 underlying)
Footnotes (9)
  • [F1]Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.
  • [F2]Performance stock units convert to shares of TDOC common stock on a one-for-one basis.
  • [F3]Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's performance stock unit and restricted stock unit awards.
  • [F4]On March 1, 2022, the reporting person was granted 14,149 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter.
  • [F5]On March 3, 2023, the reporting person was granted 34,412 restricted stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter.
  • [F6]Each performance stock unit represents a contingent right to receive one share of TDOC common stock.
  • [F7]Performance award amount determined based on metrics in respect of the issuer's 2023 financial results.
  • [F8]The performance stock units vest as to one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter.
  • [F9]On March 1, 2024, the reporting person earned 11,728 performance stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter.

Issuer

Teladoc Health, Inc.

CIK 0001477449

Entity typeother

Related Parties

1
  • filerCIK 0001830520

Filing Metadata

Form type
4
Filed
Mar 4, 7:00 PM ET
Accepted
Mar 5, 4:07 PM ET
Size
18.5 KB